Requests that the FDA determine whether the Reference Listed Drug (RLD) PEPCID RPD™ (famotidine) ORALLY DISINTEGRATING TABLETS, 20 mg and 40 mg; New Drug Application (NDA) 020752 of MERCK RESEARCH LABORATORIES DIV MERCK CO INC. has been voluntarily withdrawn from sale for safety or efficacy reasons
🏛 Food and Drug Administration (FDA)FDA-2026-P-7178
Documents
3
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jun 30, 2026No comment period
- Supporting & Related Material· Jun 30, 2026